Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Saved in:
| Title: | Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer. |
|---|---|
| Authors: | Goldkorn A; Division of Medical Oncology, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.; USC Norris Comprehensive Cancer Center, Los Angeles, California., Tangen C; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, Washington., Plets M; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, Washington., Bsteh D; Division of Medical Oncology, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.; USC Norris Comprehensive Cancer Center, Los Angeles, California., Xu T; Division of Medical Oncology, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.; USC Norris Comprehensive Cancer Center, Los Angeles, California., Pinski JK; USC Norris Comprehensive Cancer Center, Los Angeles, California., Ingles S; Keck School of Medicine of USC, Los Angeles, California., Triche TJ; Children's Hospital Los Angeles, University of Southern California, Los Angeles., MacVicar GR; Illinois CancerCare PC, Peoria., Vaena DA; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City., Crispino AW; UsTOO Las Vegas, Las Vegas, Nevada., McConkey DJ; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, Maryland., Lara PN Jr; UC Davis Comprehensive Cancer Center, Sacramento, California., Hussain MHA; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Quinn DI; USC Norris Comprehensive Cancer Center, Los Angeles, California., Dorff TB; City of Hope Comprehensive Cancer Center, Duarte, California., Lerner SP; Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Thompson I Jr; Christus Health, San Antonio, Texas., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City. |
| Source: | JAMA network open [JAMA Netw Open] 2024 Oct 01; Vol. 7 (10), pp. e2437871. Date of Electronic Publication: 2024 Oct 01. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2024.37871 |
